Transarterial chemoembolization plus lenvatinib with or without programmed death-1 inhibitors for patients with unresectable hepatocellular carcinoma: A propensity score matching s...

por Guo, Peng, Pi, Xingtao, Gao, Feng, Li, Qiang, Li, Duqiang, Feng, Wendong, Cao, Wendong
Publicado 2022